PIERGIUSEPPE OREZZI
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
Papers in
- Pharmacology 11
- Microbial Natural Products and Biosynthesis 11
-
- Molecular spectroscopy and chirality 3
- Co-authors
- Federico Arcamone (6 shared papers)Giuseppe Cassinelli (8 shared papers)A. Grein (3 shared papers)Celestino Spalla (2 shared papers)G. FRANCESCHI (5 shared papers)Rosanna Mondelli (2 shared papers)Silvana Penco (1 shared paper)A. Di Marco (2 shared papers)
- Journals
- Biotechnology and Bioengineering (2 papers)Journal of the American Chemical Society (2 papers)Nature (2 papers)Tetrahedron Letters (2 papers)Cellular and Molecular Life Sciences (2 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
PIERGIUSEPPE OREZZI
14 papers receiving 1.2k citations
PIERGIUSEPPE OREZZI's Hit Papers
Peers
Comparison fields: 5 of 77
- Toxicology 228
- Pharmacology 366
- Organic Chemistry 319
- Molecular Biology 461
- Cardiology and Cardiovascular Medicine 165
Countries citing papers authored by PIERGIUSEPPE OREZZI
This map shows the geographic impact of PIERGIUSEPPE OREZZI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PIERGIUSEPPE OREZZI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PIERGIUSEPPE OREZZI more than expected).
Fields of papers citing papers by PIERGIUSEPPE OREZZI
This network shows the impact of papers produced by PIERGIUSEPPE OREZZI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PIERGIUSEPPE OREZZI. The network helps show where PIERGIUSEPPE OREZZI may publish in the future.
Co-authors
The 25 scholars most cited alongside PIERGIUSEPPE OREZZI, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius Hit paper breakdown → | 1969 | 529 |
| 2 | 1964 | 213 | |
| 3 | 1964 | 189 | |
| 4 | 1964 | 137 | |
| 5 | 1964 | 107 | |
| 6 | 2000 | 58 | |
| 7 | 1968 | 57 | |
| 8 | 1968 | 39 | |
| 9 | 1967 | 38 | |
| 10 | Experimental studies on distamycin A--a new antibiotic with cytotoxic activity. | 1962 | 20 |
| 11 | 1972 | 17 | |
| 12 | 1988 | 15 | |
| 13 | 1992 | 14 | |
| 14 | 1968 | 8 |
About PIERGIUSEPPE OREZZI
PIERGIUSEPPE OREZZI is a scholar working on Pharmacology, Spectroscopy, Toxicology, Microbiology and Organic Chemistry, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (11 papers), Molecular spectroscopy and chirality (3 papers), Antimicrobial Peptides and Activities (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Protease and Inhibitor Mechanisms (1 paper), Synthesis of β-Lactam Compounds (1 paper), Metal complexes synthesis and properties (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). The work is most often cited by research in Toxicology (228 citations), Pharmacology (366 citations), Organic Chemistry (319 citations), Molecular Biology (461 citations) and Cardiology and Cardiovascular Medicine (165 citations). PIERGIUSEPPE OREZZI has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Federico Arcamone, Giuseppe Cassinelli, A. Grein, Celestino Spalla, G. FRANCESCHI, Rosanna Mondelli, Silvana Penco, A. Di Marco, Marcello Gaetani and Biancamaria Scarpinato. Their work appears in journals such as Biotechnology and Bioengineering, Journal of the American Chemical Society, Nature, Tetrahedron Letters and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.